Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.

Chest - 1 Nov 2007

Hizawa Nobuyuki, Makita Hironi, Nasuhara Yasuyuki, Betsuyaku Tomoko, Itoh Yoko, Nagai Katsura, Hasegawa Masaru, Nishimura Masaharu

Abstract excerpt

BACKGROUND: COPD is characterized by a persistent airflow limitation that is not fully reversible; thus, the reversibility of airflow limitations in response to a bronchodilator is an important component of COPD. Several studies have established that two common nonsynonymous polymorphisms in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Agonists
Share to Albuterol
Share to Bronchodilator Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Longitudinal Studies

Share to Pulmonary Disease, Chronic Obstructive

Share to Receptors, Adrenergic, beta-2

Share to Respiratory Function Tests

Source

Identifiers

PMID: 17890463
DOI: 10.1378/chest.07-1103

Genes

ADRB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-17890463-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.PMID 17890463Read ↗

Association between bronchodilating response to short-acting beta-agonist and non-synonymous single-nucleotide polymorphisms of beta-adrenoceptor gene.Semantic proximity Read ↗

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma.Semantic proximity Read ↗

Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.Semantic proximity Read ↗

Beta2-adrenergic receptor gene haplotypes and bronchodilator response in Egyptian patients with chronic obstructive pulmonary disease.Semantic proximity Read ↗

Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.Semantic proximity Read ↗

Lung function response to 12-week treatment with combined inhalation of long-acting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease.Semantic proximity Read ↗

Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.Semantic proximity Read ↗

Beta2-adrenoceptor polymorphisms and obstructive airway diseases: important issues of study design.Semantic proximity Read ↗

Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.Semantic proximity Read ↗

β2-Adrenergic Receptor (ADRB2) Gene Polymorphisms and Risk of COPD Exacerbations: The Rotterdam StudySemantic proximity Read ↗

beta-Adrenergic receptor polymorphisms and response to salmeterol.Semantic proximity Read ↗

beta-Adrenergic receptor polymorphisms: relationship to the beta-agonist controversy and clinical implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.